Seeking Alpha

Charles River Laboratories (CRL +6.4%) and Wuxi PharmaTech (WX) call off their merger agreement...

Charles River Laboratories (CRL +6.4%) and Wuxi PharmaTech (WX) call off their merger agreement following continued investor opposition. The $1.6B deal would have been the largest foreign takeover of a Chinese company; instead, Charles River will pay Wuxi a $30M breakup fee and begin a $500M share buyback program. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector